There is more going on in myotonic dystrophy type 1 than just alternative splicing

(Baylor College of Medicine) A novel mouse model shows that, although many of the characteristics of DM1 result from alternative splicing defects, in addition there are other mechanisms at play and therefore other potential targets to treat this disease.
Source: EurekAlert! - Biology - Category: Biology Source Type: news